173 Avsnitt

  1. Ep175: Andy Scharenberg on in vivo CAR-T cell therapies

    Publicerades: 2025-03-16

  2. Ep174: Najat Khan on the TechBio Movement

    Publicerades: 2025-03-03

  3. Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders

    Publicerades: 2025-02-11

  4. Ep172: Mostafa Ronaghi on Studying Live Cells at Scale

    Publicerades: 2025-01-27

  5. Ep171: Ram Aiyar on RNA Editing Medicines

    Publicerades: 2025-01-13

  6. Ep170: David Schenkein on Investing in the Future of Biotech

    Publicerades: 2025-01-02

  7. Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines

    Publicerades: 2024-12-11

  8. Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer

    Publicerades: 2024-11-25

  9. Ep167: Leslie Williams on transfer RNA therapies

    Publicerades: 2024-11-06

  10. Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity

    Publicerades: 2024-10-15

  11. Ep165: Zach Hornby on Tackling Cancer Drug Resistance

    Publicerades: 2024-09-26

  12. Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients

    Publicerades: 2024-09-05

  13. Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases

    Publicerades: 2024-08-14

  14. Ep162: Sean McClain on AI for Biologic Drug Discovery

    Publicerades: 2024-07-16

  15. Ep161: Jeff Stein on a Long-Lasting Flu Drug

    Publicerades: 2024-07-01

  16. Ep160: Abe Ceesay on Precision Neuroscience

    Publicerades: 2024-06-17

  17. Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease

    Publicerades: 2024-06-03

  18. Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery

    Publicerades: 2024-05-20

  19. Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery

    Publicerades: 2024-05-01

  20. Ep156: David Liu on New Tools and Techniques for Biology

    Publicerades: 2024-04-16

1 / 9

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Visit the podcast's native language site